![Jamie Dananberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jamie Dananberg
Hoofd Techniek/Wetenschap/O&O bij
ANNEXON, INC.
Vermogen: 669 814 $ op 31-05-2026
Profiel
Jamie Dananberg is currently Chief Medical Officer & Executive Vice President at Annexon, Inc. since 2023 and serves as a Trustee at Keck Graduate Institute of Applied Life Sciences.
Former roles include VP-Translational Medicine & Tailored Therapeutics at Eli Lilly & Co. from 2000 to 2012, Executive Vice President at Takeda Pharmaceutical Co., Ltd. from 2012 to 2015, and Chief Medical Officer at Unity Biotechnology, Inc. from 2016 to 2023.
Education includes undergraduate and doctorate degrees from Tufts University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ANNEXON, INC. 0,08% | 02-03-2026 | 123.582 ( 0,08% ) | 669 814 $ | 31-05-2026 |
Actieve functies van Jamie Dananberg
| Bedrijven | Functie | Begin |
|---|---|---|
| ANNEXON, INC. | Hoofd Techniek/Wetenschap/O&O | 27-07-2023 |
Keck Graduate Institute of Applied Life Sciences
 Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Bestuurslid | - |
Eerdere bekende functies van Jamie Dananberg
| Bedrijven | Functie | Einde |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 30-04-2023 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01-10-2015 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-09-2012 |
Opleiding van Jamie Dananberg
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
71
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keck Graduate Institute of Applied Life Sciences
Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Kies MarketScreener 
